Finance & Blockchain's 4.1pp Series B share loss cedes ground to Software's 2pp gain in France and Germany

Across the 3,944 Series B deals Brouky tracks in France and Germany, Finance & Blockchain lost 4.1 percentage points of funding share, retreating from 12.8% in 2021 to 8.7% in 2024, ceding ground to Software & Developer Tools, which increased its share by 2 percentage points, growing from 34.9% to 36.9% over the same period, though this may partly reflect expanding data coverage.

Healthcare & Life Sciences also expanded its share, albeit more modestly, by 0.9 percentage points, rising from 13.3% to 14.2%. The median Series B round size in Healthcare & Life Sciences reached €9,187,156, notably higher than Software’s median of €6,000,000, indicating larger capital injections per deal despite a smaller share increase.